1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > EU5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

EU5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020

Summary

GlobalData’s new report, "EU5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020", provides key market data on the Europe Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures. The report provides procedure volumes within market segments - Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal - Non-Covered Biliary Stenting Procedures, ERCP Metal - Partially Covered Biliary Stenting Procedures and ERCP Metal - Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes by segment - Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures (ERCP Plastic Biliary Stenting Procedures and ERCP Metal Biliary Stenting Procedures (ERCP Metal - Non-Covered Biliary Stenting Procedures, ERCP Metal - Partially Covered Biliary Stenting Procedures and ERCP Metal - Fully Covered Biliary Stenting Procedures)) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures without Stenting.
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

Table Of Contents

EU5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Segmentation 6
2.3 Definitions of Procedures Covered in the Report 7
3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5 8
3.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, 2005-2020 8
3.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, 2005-2020, Category Comparison by Procedures, 2005-2020 9
3.3 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, 2005-2013 10
3.4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, 2013-2020 12
4 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France 14
4.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, 2005-2013 14
4.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, 2013-2020 16
4.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, 2005-2013 18
4.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, 2013-2020 20
4.2.2.1 ERCP Metal Biliary Stenting Procedures, France, 2005-2013 22
4.2.2.2 ERCP Metal Biliary Stenting Procedures, France, 2013-2020 24
5 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Germany 26
5.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Germany, 2005-2013 26
5.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Germany, 2013-2020 28
5.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Germany, 2005-2013 30
5.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Germany, 2013-2020 32
5.2.2.1 ERCP Metal Biliary Stenting Procedures, Germany, 2005-2013 34
5.2.2.2 ERCP Metal Biliary Stenting Procedures, Germany, 2013-2020 36
6 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Italy 38
6.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Italy, 2005-2013 38
6.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Italy, 2013-2020 40
6.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Italy, 2005-2013 42
6.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Italy, 2013-2020 43
6.2.2.1 ERCP Metal Biliary Stenting Procedures, Italy, 2005-2013 44
6.2.2.2 ERCP Metal Biliary Stenting Procedures, Italy, 2013-2020 46
7 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Spain 48
7.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Spain, 2005-2013 48
7.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Spain, 2013-2020 50
7.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Spain, 2005-2013 52
7.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Spain, 2013-2020 54
7.2.2.1 ERCP Metal Biliary Stenting Procedures, Spain, 2005-2013 56
7.2.2.2 ERCP Metal Biliary Stenting Procedures, Spain, 2013-2020 58
8 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United Kingdom 60
8.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United Kingdom, 2005-2013 60
8.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United Kingdom, 2013-2020 62
8.2.1 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United Kingdom, 2005-2013 64
8.2.2 Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United Kingdom, 2013-2020 66
8.2.2.1 ERCP Metal Biliary Stenting Procedures, United Kingdom, 2005-2013 68
8.2.2.2 ERCP Metal Biliary Stenting Procedures, United Kingdom, 2013-2020 70
9 Appendix 72
9.1 Research Methodology 73
9.1.1 Coverage 73
9.1.2 Secondary Research 73
9.1.3 Primary Research 74
9.1.4 Market Modeling and Forecasting 75
9.1.5 Company Share Analysis 78
9.1.6 Distribution Share Analysis 79
9.2 Expert Panel 79
9.3 GlobalData Consulting 80
9.4 Contact Us 80
9.5 Disclaimer 80

1.1 List of Tables
Table 1: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, 2005-2020 8
Table 2: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, Category Comparison by Procedures, 2005-2020 9
Table 3: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, Historic, 2005-2013 11
Table 4: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, Forecast, 2013-2020 13
Table 5: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, Historic, 2005-2013 15
Table 6: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, Forecast, 2013-2020 17
Table 7: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, Historic, 2005-2013 19
Table 8: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, Forecast, 2013-2020 21
Table 9: ERCP Metal Biliary Stenting Procedures, France, Historic, 2005-2013 23
Table 10: ERCP Metal Biliary Stenting Procedures, France, Forecast, 2013-2020 25
Table 11: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Germany, Historic, 2005-2013 27
Table 12: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Germany, Forecast, 2013-2020 29
Table 13: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Germany, Historic, 2005-2013 31
Table 14: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Germany, Forecast, 2013-2020 33
Table 15: ERCP Metal Biliary Stenting Procedures, Germany, Historic, 2005-2013 35
Table 16: ERCP Metal Biliary Stenting Procedures, Germany, Forecast, 2013-2020 37
Table 17: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Italy, Historic, 2005-2013 39
Table 18: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Italy, Forecast, 2013-2020 41
Table 19: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Italy, Historic, 2005-2013 42
Table 20: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Italy, Forecast, 2013-2020 43
Table 21: ERCP Metal Biliary Stenting Procedures, Italy, Historic, 2005-2013 45
Table 22: ERCP Metal Biliary Stenting Procedures, Italy, Forecast, 2013-2020 47
Table 23: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Spain, Historic, 2005-2013 49
Table 24: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Spain, Forecast, 2013-2020 51
Table 25: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Spain, Historic, 2005-2013 53
Table 26: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Spain, Forecast, 2013-2020 55
Table 27: ERCP Metal Biliary Stenting Procedures, Spain, Historic, 2005-2013 57
Table 28: ERCP Metal Biliary Stenting Procedures, Spain, Forecast, 2013-2020 59
Table 29: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United Kingdom, Historic, 2005-2013 61
Table 30: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United Kingdom, Forecast, 2013-2020 63
Table 31: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United Kingdom, Historic, 2005-2013 65
Table 32: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United Kingdom, Forecast, 2013-2020 67
Table 33: ERCP Metal Biliary Stenting Procedures, United Kingdom, Historic, 2005-2013 69
Table 34: ERCP Metal Biliary Stenting Procedures, United Kingdom, Forecast, 2013-2020 71
Table 35: Total Number of Primary Research Participants, General Surgery Market, by Country 75

1.2 List of Figures
Figure 1: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, 2005-2020 8
Figure 2: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, Category Comparison by Procedures, 2005-2020 9
Figure 3: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, Historic, 2005-2013 10
Figure 4: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, EU5, Forecast, 2013-2020 12
Figure 5: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, Historic, 2005-2013 14
Figure 6: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, France, Forecast, 2013-2020 16
Figure 7: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, Historic, 2005-2013 18
Figure 8: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, France, Forecast, 2013-2020 20
Figure 9: ERCP Metal Biliary Stenting Procedures, France, Historic, 2005-2013 22
Figure 10: ERCP Metal Biliary Stenting Procedures, France, Forecast, 2013-2020 24
Figure 11: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Germany, Historic, 2005-2013 26
Figure 12: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Germany, Forecast, 2013-2020 28
Figure 13: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Germany, Historic, 2005-2013 30
Figure 14: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Germany, Forecast, 2013-2020 32
Figure 15: ERCP Metal Biliary Stenting Procedures, Germany, Historic, 2005-2013 34
Figure 16: ERCP Metal Biliary Stenting Procedures, Germany, Forecast, 2013-2020 36
Figure 17: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Italy, Historic, 2005-2013 38
Figure 18: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Italy, Forecast, 2013-2020 40
Figure 19: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Italy, Historic, 2005-2013 42
Figure 20: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Italy, Forecast, 2013-2020 43
Figure 21: ERCP Metal Biliary Stenting Procedures, Italy, Historic, 2005-2013 44
Figure 22: ERCP Metal Biliary Stenting Procedures, Italy, Forecast, 2013-2020 46
Figure 23: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Spain, Historic, 2005-2013 48
Figure 24: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Spain, Forecast, 2013-2020 50
Figure 25: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Spain, Historic, 2005-2013 52
Figure 26: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, Spain, Forecast, 2013-2020 54
Figure 27: ERCP Metal Biliary Stenting Procedures, Spain, Historic, 2005-2013 56
Figure 28: ERCP Metal Biliary Stenting Procedures, Spain, Forecast, 2013-2020 58
Figure 29: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United Kingdom, Historic, 2005-2013 60
Figure 30: Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, United Kingdom, Forecast, 2013-2020 62
Figure 31: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United Kingdom, Historic, 2005-2013 64
Figure 32: Endoscopic Retrograde Cholangiopancreatography (ERCP) Biliary Stenting Procedures, United Kingdom, Forecast, 2013-2020 66
Figure 33: ERCP Metal Biliary Stenting Procedures, United Kingdom, Historic, 2005-2013 68
Figure 34: ERCP Metal Biliary Stenting Procedures, United Kingdom, Forecast, 2013-2020 70
Figure 35: GlobalData Epidemiology-Based Forecasting Model 77
Figure 36: GlobalData Capital Equipment-Based Forecasting Model 78
Figure 37: Primary Interviews by Participant Type (%) 79

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 35000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.